NAGER NANCY 4

4 · CANDELA CORP /DE/ · Filed Feb 2, 2010

Form 4

Period: 2010-01-05

Director

Transactions

Disposition to Issuer
Common Stock
2010-01-05−2,000→ 0 total
Disposition to Issuer
Stock Appreciation Rights (right to buy)
2010-01-05−40,000→ 0 total
Exercise: $4.29Exp: 2018-01-25→ Common Stock, $0.01 par value per share (40,000 underlying)
Disposition to Issuer
Stock Appreciation Rights (right to buy)
2010-01-05−30,000→ 0 total
Exercise: $15.33Exp: 2016-01-30→ Common Stock, $0.01 par value per share (30,000 underlying)
Disposition to Issuer
Non Qualified Stock Option (right to buy)
2010-01-05−15,000→ 0 total
Exercise: $9.50Exp: 2015-02-11→ Common Stock, $0.01 par value per share (15,000 underlying)

Footnotes (4)

[F1]These shares were disposed of pursuant to a merger agreement between the Issuer and Syneron Medical Ltd. ("Syneron") in exchange for 582 ordinary shares of Syneron having a market value of $10.39 per share at the close of trading on the effective date of the merger.
[F2]The stock-settled stock appreciation rights, which were exercisable in two equal installments beginning on January 19, 2009, were cancelled by Candela.
[F3]The stock-settled stock appreciation rights, which were exercisable in two installments beginning on January 30, 2007, were cancelled by Candela.
[F4]The non-qualified stock options, which were exercisable in one installment beginning on February 11, 2005, were cancelled by Candela.

Documents

1 file